Baycrest

A+ Our commitment to innovation is driving our focus on generating transformative "next" practices. This year we opened a new Innovation, Technology and Design Laboratory, where scientists, clinicians, engineers, architects, designers and artists collaborate with seniors, caregivers and care providers to develop new products, technologies and processes that will improve care and quality of life as we age. We also have great expectations for our new neuroeducational program which is being supported by a combined $5 million Federal Development and Ontario Brain Institute grant. The grant will help fund the development and testing of cognitive games for children to optimize classroom learning and skills acquisition. Based on scientific findings from this process, novel means of strengthening cognitive functions in the human brain throughout the lifespan will be identified and developed. We continue to make progress in assembling and leading the Seniors Quality Leap Initiative – a collaboration of 13 of the highest-performing organizations in our sector in North America. The aim is to benchmark and redefine optimal performance metrics and improvement activities. The network also provides an opportunity to collaboratively test the next generation of senior care innovations. We also launched the MDS Scorecard – a first for the long-term care sector anywhere in the world. The scorecard gives real-time feedback to care providers on the health status of our nursing home residents and our hospital patients as well as any potential risks that need addressing. At the same time, the scorecard provides valuable data for system-wide planning, quality monitoring and accountability. We made considerable headway in our efforts to commercialize our know-how so we can share it on a global scale. For instance, we are building our in-house capacity with new entrepreneurs- in-residence in the Centre for Brain Fitness who Accreditation Canada has given Baycrest a top tier ranking for excellence in senior care, safety and operations management, citing three of our programs as exemplars of leading practice for the country. work with clinicians and scientists to develop and market our intellectual property. We are also excited to see Cogniciti, our for-profit company with MaRS, launch a new on-line cognitive assess- ment tool later this year. Additionally, we signed a letter of interest with Peking Union Medical College to create a partnership that will bring our expertise in geriatric rehabilitation to China. As you can see, much has been accomplished as we work to implement our vision for the "Next Generation of Baycrest." Our history as an organization has been to continually evolve, aspire to new heights, and achieve despite the obstacles. We are now about to embark on a refreshing of our strategic plan that will emphasize three critical imperatives: "best in class" quality, significant innovation, and top-notch efficiency. Achieving great outcomes in each of these areas will secure our position as the global leader in aging and brain health. The direction we are headed has been largely influenced by Dr. Anthony Melman, who recently stepped down as chair of the Baycrest Board of Directors after five years of invaluable leadership to this organization. On behalf of our entire orga- nization, we want to thank Tony for his enormous contributions to Baycrest. We would also like to extend our deepest grati- tude to our hardworking and dedicated staff, our extraordinary volunteers, board and committee members, generous donors and our clients and families, who are responsible for Baycrest's successes and commitment to excellence. Baycrest is just a name. It is the people who make this organization thrive and strive to be the best. GARRY FOSTER Chair, Baycrest Board of Directors DR. WILLIAM REICHMAN President and Chief Executive Officer, Baycrest 2011/12 Baycrest and Baycrest Foundation Annual Report 3

• Cover